People | April 14, 2025
Shaik Barak Tulla joins Sun Pharma as Sr. VP
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
The product will be launched in Q1FY26
The supply of these goods is set to commence within the first quarter of FY26
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Strengthening capabilities in Peptide Therapeutics and CDMO services
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Subscribe To Our Newsletter & Stay Updated
